1. Research Funding
  2. FY 2022 Financial Management Plan

FY 2022 Financial Management Plan

NIBIB FY22 paylines by grant mechanism are shown along with administrative budget reductions, if any.
GRANTS MECHANISM PERCENTILE PAYLINE (see notes below for superscripts) ADMINISTRATIVE BUDGET REDUCTION
R01 (Parent FOAs) 19%1
  • 10% reduction for competing awards to Early-Stage Investigators (ESIs) and modular budgets
  • 15% reduction for competing awards to non-ESIs with non-modular budgets
  • Competing awards limited to four years
R01 (Academic Industrial Partnership FOAs) Select Pay2
  • 10% reduction for competing awards to Early-Stage Investigators (ESIs) and modular budgets
  • 15% reduction for competing awards to non-ESIs with non-modular budgets
  • Competing awards limited to five years
R21 Select Pay2 No reduction
R15, R03 Select Pay2 No reduction
P41 Select Pay2

No reduction
U01 Select Pay2
  • 10% reduction for competing awards to Early-Stage Investigators (ESIs) and modular budgets
  • 15% reduction for competing awards to non-ESIs with non-modular budgets
  • Competing awards limited to four years (Bioengineering Research Partnership U01s limited to five years)
F32, F33, T32, K01, K08, K23, K24, K25, K99/R00, SBIR, STTR Select Pay2 No reduction
Expanded Opportunity Zone (EOZ) Select Pay3  Negotiated

Notes:

1 The percentile payline applies to R01 applications submitted to parent R01 Funding Opportunity Announcements (FOAs). Other percentiled and non-percentiled R01 applications are select pay. The percentile payline for new investigator R01 applications submitted to parent R01 FOAs is 5% higher, i.e. 24%. See policy at New investigator Funding Policy.

2 No fixed payline exists. Applications are considered for funding on a case-by-case basis based on programmatic considerations and available funds.

3The NIBIB Expanded Opportunity Zone (EOZ) policy allows selected funding for some applications with percentile scores beyond the payline. Criteria are outlined at EOZ.